Quote:
Originally Posted by lkagele
8 - Just a prediction here, Merck's new drug will be eerily similar to Merck's Ivermectin. $7 vs. $0.50.
That's what I think I know.
|
$700 not $7 for 5 days of treatment.
It also has fewer modes of action, mainly in that Merck's new offering is only a protease inhibitor similar to IVM. The difference is that IVM competitively binds to the spike protein as well and that is probably why IVM works so well as prophylaxis. There are also about 7 lesser methods that IVM uses, like the Importin alpha and beta channels but hey, at least they aren't using Merck's new offering in horses. Merckmectin also has about half the efficacy, but at least now all the pharma shills will be touting it to the skies, so a win is a win I guess.